Recordati Industria Chimica e Farmaceutica S.p.A.

Factors to consider:

• Company pays dividends (semi-annually): last record date 2025-11-25, amount 0.73$ (Y2.23%)
• Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

• 2024-12-31 to 2025-12-31 estimated range: [44.36$, 61.77$]
• 2025-12-31 to 2026-12-31 estimated range: [47.48$, 65.64$]

Financial Metrics affecting the RCDTF estimates:

• Negative: with PPE of 19.9 at the end of fiscal year the price was very high
• Positive: Operating profit margin, % of 27.28 > 18.64
• Positive: Return on assets ratio (scaled to [-100,100]) of 7.50 > 6.04
• Positive: 18.93 < Shareholder equity ratio, % of 36.55 <= 41.86
• Positive: 5.52 < Industry operating cash flow per share per price (median), % of 8.11
• Positive: -14.38 < Investing cash flow per share per price, % of -8.00
• Positive: Industry earnings per price (median), % of 5.67 > 4.43
• Negative: Operating cash flow per share per price, % of 5.39 <= 6.82
• Positive: Industry inventory ratio change (median), % of -0.66 <= -0.15